Sonoma Pharmaceuticals
SNOA · NASDAQ
$1.15+$0.03 (+2.68%)TodayMarket closed ·
Prev close $1.12
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 34.9% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.3162 | -$0.32 | −1.2% |
| Q1 FY26 | -$0.5233 | -$0.76 | −45.2% |
| Q3 FY25 | -$0.7038 | -$0.63 | +10.5% |
| Q2 FY25 | -$1.02 | -$0.59 | +42.2% |
| Q1 FY25 | -$1.22 | -$1.40 | −14.4% |
| Q3 FY24 | -$4.28 | -$1.60 | +62.7% |
| Q2 FY24 | -$4.90 | -$5.80 | −18.5% |
| Q2 FY20 | -$24.07 | -$18.20 | +24.4% |
Earnings calls
- Earnings call Q2 2019
- Earnings call Q1 2019
- Earnings call Q4 2018
- Special Call - Sonoma Pharmaceuticals, Inc.
- Earnings call Q3 2018
- Earnings call Q2 2018
- SNOA - Earnings call 2 2018
- Earnings call Q1 2018
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.